179 related articles for article (PubMed ID: 6143491)
21. Comparative metabolism of E-5-(2-bromovinyl)-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cells.
Ayisi NK; Wall RA; Wanklin RJ; Machida H; De Clercq E; Sacks SL
Mol Pharmacol; 1987 Apr; 31(4):422-9. PubMed ID: 3472064
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate potentiates anti-herpes simplex virus type 1 activity of E-5-(2-bromovinyl)-2'-deoxyuridine.
Pancheva SN
Acta Virol; 1995 Apr; 39(2):117-9. PubMed ID: 7676937
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.
De Clercq E; Descamps J; Verhelst G; Walker RT; Jones AS; Torrence PF; Shugar D
J Infect Dis; 1980 May; 141(5):563-74. PubMed ID: 6246180
[TBL] [Abstract][Full Text] [Related]
24. Effect of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil on Epstein-Barr virus antigen expression in P3HR-1 cells: comparison with acyclovir.
Färber I; Klinger C; Wutzler P; Thiel KD; Reefschläger J; Herrmann G
Acta Virol; 1987 Jan; 31(1):13-8. PubMed ID: 2883852
[TBL] [Abstract][Full Text] [Related]
25. Different antiviral potencies of BV-araU and related nucleoside analogues against herpes simplex virus type 1 in human cell lines and Vero cells.
Machida H; Nishitani M; Suzutani T; Hayashi K
Microbiol Immunol; 1991; 35(11):963-73. PubMed ID: 1663576
[TBL] [Abstract][Full Text] [Related]
26. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
Kawai H; Yoshida I; Suzutani T
Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
[TBL] [Abstract][Full Text] [Related]
27. Differential inhibition of herpes simplex viruses, type 1 (HSV-1) an type 2 (HSV-2), by (E)-5-(2-X-vinyl)-2'-deoxyuridines.
de Clercq E; Verhelst G; Descamps J; Bergstrom DE
Acta Microbiol Acad Sci Hung; 1981; 28(3):307-12. PubMed ID: 6272553
[No Abstract] [Full Text] [Related]
28. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2.
Balzarini J; Bohman C; De Clercq E
J Biol Chem; 1993 Mar; 268(9):6332-7. PubMed ID: 8384209
[TBL] [Abstract][Full Text] [Related]
29. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
30. [Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus].
Temicheva EV; Malinovskaia VV; Manakhova LS; Mironova LL; Galegov GA
Biull Eksp Biol Med; 1987 Oct; 104(10):490-2. PubMed ID: 2823929
[TBL] [Abstract][Full Text] [Related]
31. Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors.
Aduma PJ; Gupta SV; De Clercq E
Antiviral Res; 1990 Mar; 13(3):111-25. PubMed ID: 2162147
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
[TBL] [Abstract][Full Text] [Related]
33. Analysis of toxic and mutagenic activities of antiherpesvirus nucleosides against HeLa cells and herpes simplex virus type 1.
Suzutani T; Machida H
Mutat Res; 1992 May; 267(1):125-31. PubMed ID: 1373847
[TBL] [Abstract][Full Text] [Related]
34. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
Schinazi RF; Nahmias AJ
Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
[TBL] [Abstract][Full Text] [Related]
35. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
De Clercq E; Descamps J; De Somer P; Barr PJ; Jones AS; Walker RT
Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2947-51. PubMed ID: 223163
[TBL] [Abstract][Full Text] [Related]
36. Nucleosides. 139. Synthesis and anticytomegalovirus and antiherpes simplex virus activity of 5'-modified analogues of 2'-fluoroarabinosylpyrimidine nucleosides.
Harada K; Matulic-Adamic J; Price RW; Schinazi RF; Watanabe KA; Fox JJ
J Med Chem; 1987 Jan; 30(1):226-9. PubMed ID: 3027334
[TBL] [Abstract][Full Text] [Related]
37. Comparative activity of various compounds against clinical strains of herpes simplex virus.
Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785
[TBL] [Abstract][Full Text] [Related]
38. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
Schnitzler P; Schön K; Reichling J
Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antiviral activity of the enantiomeric forms of carba-5-iodo-2'-deoxyuridine and carba-(E)-5-(2-bromovinyl)-2'-deoxyuridine.
Balzarini J; Baumgartner H; Bodenteich M; De Clercq E; Griengl H
J Med Chem; 1989 Aug; 32(8):1861-5. PubMed ID: 2547072
[TBL] [Abstract][Full Text] [Related]
40. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
